zagdad, I would agree that the stock is underpriced but now that it has moved up to the $.90 mark it seems to be getting closer to a fair valuation. There is about 150M shares out fully diluted so we are looking at an FD market cap of about $135M at this point.
The upside potential does indeed appear to be significant, and that is keeping me from selling much more than a modest amount of my position. They recently updated their presentation, it does a great job at showing the upside that has been created by the merger with Benchmark.
I believe the biggest reason that the stock goes through periods of languishing is that it is not on a listed exchange. The OTC market is highly illiquid so the institutions rarely get involved with these stocks.
They have told us that they plan to issue an amended 8K on the Benchmark merger by the end of this month, which will show how the company would have looked if they had been merged as of the beginning of 2016. I believe there will be some good info about how the merged business should do going forward in that amended 8K.
Once they get that amended 8K out of the way they should be able to concentrate on the registration statement for the recently issued stock, which I believe is the last step required by Nasdaq to get listed.
The 1Q numbers were somewhat disappointing (I was expecting a lot more sales than $5M) but they did have positive EBITDA finally and their cash flow before working capital changes was a relatively small deficit (about $300K). This tells me that next quarter stands a good chance of showing positive earnings (as adjusted for all the weird GAAP stuff).
News 
Market Data 
Discover 
